United States Patent and Trademark Office
Searching AppFT Database...2017.9.21
Results of Search in AppFT Database for:
"Supercritical Fluid": 14542 applications.
Hits 1 through 500 out 14542

 
กก PUB. APP. NO. Title
1 20170271141 Fast Modulation with Downstream Homogenisation
2 20170271039 HIGH-ASPECT RATIO STRUCTURE PRODUCTION METHOD, ULTRASONIC PROBE PRODUCTION METHOD USING SAME, AND HIGH-ASPECT RATIO STRUCTURE
3 20170271006 MEMORY CELLS HAVING A PLURALITY OF RESISTANCE VARIABLE MATERIALS
4 20170268464 ENGINE GENERATING ENERGY THROUGH PHYSICAL AND CHEMICAL ENERGY CONVERSIONS OF A COMPRESSED GASEOUS FUEL
5 20170268169 ARRAY FOR PROCESSING MATERIALS
6 20170268030 METHODS OF PRODUCTION OF PRODUCTS OF METABOLIC PATHWAYS
7 20170267897 PRESSURE-SENSITIVE ADHESIVE SHEET
8 20170267850 FOAM COMPOSITIONS AND USES THEREOF
9 20170267849 FOAM COMPOSITIONS AND USES THEREOF
10 20170267848 FOAM COMPOSITIONS AND USES THEREOF
11 20170267847 FOAM COMPOSITIONS AND USES THEREOF
12 20170267846 FOAM COMPOSITIONS AND USES THEREOF
13 20170267845 FOAM COMPOSITIONS AND USES THEREOF
14 20170267697 3-(1H-IMIDAZO[4,5-C]PYRIDIN-2-YL)-1H-PYRAZOLO[3,4-C]PYRIDINE AND THERAPEUTIC USES THEREOF
15 20170267688 ALDOSTERONE SYNTHASE INHIBITORS
16 20170267685 HETEROARYL COMPOUNDS AND USES THEREOF
17 20170267684 A DEUTERATED TRIAZOLOPYRIDAZINE AS A KINASE MODULATOR
18 20170267682 6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
19 20170267680 Pyrimidone derivatives and their use in the treatment, amelioration or prevention of a viral disease
20 20170267673 CYCLOPROPYL FUSED THIAZIN-2-AMINE COMPOUNDS AS BETA-SECRETASE INHIBITORS AND METHODS OF USE
21 20170267666 DIHYDROPYRIDINONE MGAT2 INHIBITORS
22 20170267658 PROCESSES FOR THE PREPARATION OF ISOTOPOLOGUES OF 3-(4-((4-(MORPHOLINOMETHYL)BENZYL)OXY)-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,- 6-DIONE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
23 20170267647 SUBSTITUTED DIAMINOCARBOXAMIDE AND DIAMINOCARBONITRILE PYRIMIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH
24 20170267634 COMPOUNDS AS CRTH2 ANTAGONIST AND USES THEREOF
25 20170266846 METHOD AND DEVICE OF MANUFACTURING FIBER-REINFORCED RESIN MATERIAL
26 20170266613 Intermediate medium heat exchanging device for supercritical water oxidation system
27 20170266245 HYDROGENATION OF CANNABIS OIL
28 20170266178 C-Met Modulator Pharmaceutical Compositions
29 20170266177 Methods for Increasing CFTR Activity
30 20170266167 ERK INHIBITORS
31 20170266104 COMPOSITION FOR ALTERING THE COLOR OF KERATIN FIBERS
32 20170263842 ENHANCED SUPERCONDUCTIVITY OF FULLERENES
33 20170263428 Impactor Spray Ion Source
34 20170263424 Two-Dimensional Separation and Imaging Technique for the Rapid Analysis of Biological Samples
35 20170263346 EQUIPMENT PROTECTING ENCLOSURES
36 20170261865 PATTERN FORMING APPARATUS AND PATTERN FORMING METHOD, MOVABLE BODY DRIVE SYSTEM AND MOVABLE BODY DRIVE METHOD, EXPOSURE APPARATUS AND EXPOSURE METHOD, AND DEVICE MANUFACTURING METHOD
37 20170261524 STANDARD SOLUTION FOR USE IN ANALYSIS OF AMINO ACIDS IN PLASMA
38 20170260710 BIOMASS STORAGE SYSTEM
39 20170260486 METHOD OF PRODUCING BEER HAVING A TAILORED FLAVOUR PROFILE
40 20170260425 PRESSURE-SENSITIVE ADHESIVE SHEET
41 20170260390 METHODS FOR PRODUCING BIOPOLYMER MATRIX COMPOSITES
42 20170260301 Process for Producing Conjugated Diene Polymer
43 20170260297 RESORBABLE CELLULOSE BASED BIOMATERIAL AND IMPLANT
44 20170260266 TSLP BINDING PROTEINS
45 20170260237 MACROCYCLIC INHIBITORS OF THE PD-1/PD-L1 AND CD80(B7-1)/PD-L1 PROTEIN/PROTEIN INTERACTIONS
46 20170260209 3-(3H-IMIDAZO[4,5-B]PYRIDIN-2-YL)-1H-PYRAZOLO[3,4-C]PYRIDINE AND THERAPEUTIC USES THEREOF
47 20170260194 CAMPTOTHECIN DERIVATIVES AND USES THEREOF
48 20170260180 DIHYDROPYRROLOPYRIDINE INHIBITORS OF ROR-GAMMA
49 20170260179 2-(1H-INDAZOL-3-YL)-1H-IMIDAZO[4,5-C]PYRIDINE AND THERAPEUTIC USES THEREOF
50 20170260176 GAMMA-DIKETONES AS WNT/BETA -CATENIN SIGNALING PATHWAY ACTIVATORS
51 20170260175 ISOINDOLINONE INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE
52 20170260172 COMPOSITIONS AND METHODS FOR ACYLATING LACTAMS
53 20170260164 CD38 INHIBITORS AND METHODS OF TREATMENT
54 20170260160 INDOLE CARBOXAMIDE COMPOUNDS
55 20170260159 TETRAZOLONE-SUBSTITUTED DIHYDROPYRIDINONE MGAT2 INHIBITORS
56 20170260156 HYDROGENATION OF CATMINT OIL
57 20170260139 NOVEL 5-AMINOTETRAHYDROQUINOLINE-2-CARBOXYLIC ACIDS AND THEIR USE
58 20170259473 PROCESS FOR FOAMING THERMOPLASTIC ELASTOMERS
59 20170259467 METHODS FOR MAKING OXIDATION RESISTANT POLYMERIC MATERIAL
60 20170258964 Porous Structures of Microbial-Derived Cellulose In Vivo Implantation
61 20170258927 FORMULATIONS AND DOSES OF PEGYLATED URICASE
62 20170258822 ANTI-OBESITY COMPOSITION
63 20170258815 CORTICOSTEROID FORMULATIONS AND METHODS FOR THE TREATMENT OF JOINT PAIN IN PATIENTS WITH DIABETES
64 20170258801 FORMULATIONS OF VILOXAZINE
65 20170258797 TREATMENTS FOR AUTOIMMUNE DISEASE
66 20170258789 DNA-PK INHIBITORS
67 20170258778 SOLID FORMS COMPRISING 4-AMINO-2-(2,6-DIOXOPIPERIDINE-3-YL)ISOINDOLINE-1,3-DIONE AND A COFORMER, COMPOSITIONS AND METHODS OF USE THEREOF
68 20170258777 Selective NR2B Antagonists
69 20170258720 PHARMACEUTICAL COMPOSITIONS, PREPARATION AND USES THEREOF
70 20170258707 TOPICAL SKIN CARE FORMULATIONS COMPRISING BOTANICAL EXTRACTS
71 20170258704 COSMETIC COMPOSITION COMPRISING AN OIL, HYDROPHOBIC SILICA AEROGEL PARTICLES, AND A HYDROCARBON-BASED BLOCK COPOLYMER PREFERABLY OBTAINED FROM AT LEAST ONE STYRENE MONOMER
72 20170258690 COMPOSITION COMPRISING AN AQUEOUS PHASE AND A FATTY PHASE THAT ARE VISUALLY DISTINCT USED FOR HAIR TREATMENT
73 20170258175 SHOE INSOLE
74 20170256398 SUBSTRATE PROCESSING APPARATUS, SUBSTRATE PROCESSING METHOD, AND STORAGE MEDIUM
75 20170256397 SUBSTRATE PROCESSING APPARATUS, SUBSTRATE PROCESSING METHOD, AND STORAGE MEDIUM
76 20170255108 EXPOSURE APPARATUS, MOVABLE BODY DRIVE SYSTEM, PATTERN FORMATION APPARATUS, EXPOSURE METHOD, AND DEVICE MANUFACTURING METHOD
77 20170255098 POSITIVE TYPE RESIST COMPOSITION FOR USE IN LIQUID IMMERSION EXPOSURE AND A METHOD OF FORMING THE PATTERN USING THE SAME
78 20170254778 PERTURBATION ION MOBILITY MASS SPECTROMETRY AND THE METHOD OF MEASURING ION MOBILITY OF SELECTED IONS
79 20170254777 METHOD TO IMPROVE THE IDENTIFICATION, QUANTIFICATION AND SPATIAL LOCALIZATION OF MULTIPLY CHARGED MOLECULES IN BIOLOGICAL SAMPLES USING ION MOBILITY INFORMATION
80 20170254776 Theoretical Collision Cross Section ("CCS") In Experimental Design
81 20170254229 SUPERCRITICAL FLUID HEAT ENGINE
82 20170253947 METHOD OF SELECTIVE EXTRACTION OF PLATINOIDS, FROM A SUPPORT CONTAINING SAME, WITH AN EXTRACTION MEDIUM CONSISTING OF A SUPERCRITICAL FLUID AND AN ORGANIC LIGAND
83 20170253819 PRODUCTION OF LIQUID HYDROCARBONS
84 20170253617 Substituted 5-Membered Heterocyclic Analogs as Protease Activated Receptor 4 (PAR-4) Antagonists
85 20170252393 EXTRACT OF TOONA SINENSIS FROM SUPERCRITICAL FLUID EXTRACTION FOR TREATING DIABETES AND METABOLIC DISEASE, THE PREPARATION METHOD AND THE USE THEREOF
86 20170252386 METHOD FOR FEEDING POULTRY
87 20170252372 VIRAL INACTIVATED BIOLOGICAL MIXTURE
88 20170252368 SODIUM NITRITE-CONTAINING PHARMACEUTICAL COMPOSITIONS
89 20170252352 METHODS OF USE AND COMBINATIONS
90 20170252333 PALONOSETRON FORMULATIONS AND USES THEREOF
91 20170252310 Iron Chelators and Use Thereof for Reducing Transplant Failure During Rejection Episodes
92 20170251673 SYNERGISTIC METHODS OF USING BENZOXABOROLE COMPOUNDS AND PRESERVATIVE GASES AS AN ANTIMICROBIAL FOR CROPS
93 20170250094 STICTION-FREE DRYING PROCESS WITH CONTAMINANT REMOVAL FOR HIGH-ASPECT RATIO SEMICONDUCTOR DEVICE STR
94 20170250062 Unknown Identification Using Collision Cross Section
95 20170248308 On-site Fuel Combustion
96 20170248040 A SYSTEM FOR HIGH EFFICIENCY ENERGY CONVERSION CYCLE BY RECYCLING LATENT HEAT OF VAPORIZATION
97 20170247812 REUSABLE NITRIDE WAFER, METHOD OF MAKING, AND USE THEREOF
98 20170247537 AQUEOUS-BASED HYDROLYTICALLY STABLE DISPERSION OF A BIODEGRADABLE POLYMER
99 20170247406 NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF
100 20170247405 OXYSTEROLS AND METHODS OF USE THEREOF
101 20170247401 COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS
102 20170247400 METFORMIN DERIVATIVES
103 20170247394 SPIRO[3H-INDOLE-3,2'-PYRROLIDIN]-2(1H)-ONE COMPOUNDS AND DERIVATIVES AS MDM2-P53 INHIBITORS
104 20170247377 DIAZINE-FUSED AMIDINES AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE
105 20170247372 PYRROLO[2,3-D]PYRIMIDINYL, PYRROLO[2,3-B]PYRAZINYL AND PYRROLO[2,3-D]PYRIDINYL ACRYLAMIDES
106 20170247336 SUBSTITUTED PYRIMIDINES AS INHIBITORS OF HIF PROLYL HYDROXYLASE
107 20170247333 BACKFUNCTIONALIZED IMIDAZOLINIUM SALTS AND NHC CARBENE-METAL COMPLEXES
108 20170246558 SUPERCRITICAL FLUID CHROMATOGRAPHY SYSTEM
109 20170246320 MUCUS PENETRATING GENE CARRIERS
110 20170246300 C5-C6-FUSED TRICYCLIC IMINOTHIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE
111 20170246299 COMPOSITIONS AND METHODS FOR TREATMENT OF PRE-CANCEROUS SKIN LESIONS
112 20170246219 BIOEFFECTIVE KRILL OIL COMPOSITIONS
113 20170246201 GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF
114 20170246191 19-NOR C3, 3-DISUBSTITUTED C21-N-PYRAZOLYL STEROIDS AND METHODS OF USE THEREOF
115 20170246155 COMPOSITIONS AND METHODS FOR SELECTIVELY DEPLETING SENESCENT CELLS
116 20170246146 POLYPHENOL FOR WOUND HEALING
117 20170246142 ISOFLAVONOID COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER
118 20170246113 OXIDIZED CELLULOSE MICROSPHERES
119 20170246111 ACTIVE-LOADED PARTICULATE MATERIALS FOR TOPICAL ADMINISTRATION
120 20170246107 TOPICAL SKIN CARE FORMULATIONS COMPRISING PLANT EXTRACTS
121 20170246106 METHODS AND COMPOSITIONS FOR MAINTAINING AND IMPROVING THE HEALTH OF SKIN
122 20170244120 INTEGRATED REFUELING STATION
123 20170243729 Ion Source
124 20170243698 PHOTOELECTRIC CONVERSION ELEMENT
125 20170242338 ACTIVE-LIGHT-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, ACTIVE-LIGHT-SENSITIVE OR RADIATION-SENSITIVE FILM, PATTERN FORMING METHOD, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE
126 20170241707 METHOD FOR THE CAPTURE OF CARBON DIOXIDE THROUGH CRYOGENICALLY PROCESSING GASEOUS EMISSIONS FROM FOSSIL-FUEL POWER GENERATION
127 20170241675 COOLING SYSTEM POWERED BY THERMAL ENERGY AND RELATED METHODS
128 20170240842 BIOEFFECTIVE KRILL OIL COMPOSITIONS
129 20170240641 Methods For Treating Type 1 Diabetes Using Glucagon Receptor Antagonistic Antibodies
130 20170240589 COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS
131 20170240567 ETHYL N-BOC PIPERIDINYL PYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS
132 20170240566 AMINO-SUBSTITUTED ANNULATED PYRIMIDINES AND USE THEREOF
133 20170240553 SUBSTITUTED PYRIMIDINE DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE DISEASES
134 20170240552 PYRAZOLO[1,5-A]PYRAZIN-4-YL DERIVATIVES
135 20170240549 TETRAHYDROPYRIDO[3',2':4,5]PYRROLO[1,2-a]PYRAZINE-2-CARBOXAMIDE DERIVATIVES USEFUL AS RSK INHIBITORS
136 20170240548 TETRACYCLIC PYRIDONE COMPOUNDS AS ANTIVIRALS
137 20170240539 Preparation and Use of Cyclic Sulfonamide Derivatives as PAR-1 Receptor Antagonists
138 20170240524 Factor XIa Inhibitors
139 20170240523 FACTOR XIa INHIBITORS
140 20170240434 ENHANCED METAL RECOVERY THROUGH OXIDATION IN LIQUID AND/OR SUPERCRITICAL CARBON DIOXIDE
141 20170239874 POLYMERIC MATERIAL FOR CONTAINER
142 20170239399 COATINGS CONTAINING MULTIPLE DRUGS
143 20170239362 Growth Hormones with Prolonged In-Vivo Efficacy
144 20170239307 COMPOSITION OF DOXYCYCLINE IN LIPOSOMES FOR THE PREVENTION, IMPROVEMENT AND/OR TREATMENT OF OCULAR PATHOLOGIES
145 20170239300 BIOEFFECTIVE KRILL OIL COMPOSITIONS
146 20170239266 PHARMACEUTICAL COMPOSITIONS FOR INHIBITING ANGIOGENESIS COMPRISING PLANT-DERIVED NATURAL COMPOUND
147 20170239264 AMINOPYRIMIDINYL COMPOUNDS
148 20170239231 METHOD FOR TREATING MOVEMENT DISORDERS WITH BEFIRADOL
149 20170239226 N-Substituted-5-Substituted Phthalamic Acids as Sortilin Inhibitors
150 20170239174 METHOD OF RAPIDLY ACHIEVING THERAPEUTIC CONCENTRATIONS OF TRIPTANS FOR TREATMENT OF MIGRAINES
151 20170238676 NOVEL CARE AND/OR MAKEUP DEVICE COMPRISING A COMPOSITION OF GEL/GEL ARCHITECTURE
152 20170238607 SMOKING ARTICLE COMPRISING AEROGEL
153 20170236959 METHOD OF INCREASING THE THICKNESS OF COLLOIDAL NANOSHEETS AND MATERIALS CONSISTING OF SAID NANOSHEETS
154 20170236700 Time of Flight Mass Spectrometer
155 20170234777 SOURCE MOUNTED MODULAR SAMPLE CONDITIONING SYSTEM
156 20170233914 Methods, processes, and apparatuses for producing dyed and welded substrates
157 20170233775 TWO-STAGE PROCESS FOR PRODUCING OIL FROM MICROALGAE
158 20170233465 TREATMENT OF MYOCARDIAL INFARCTION USING TGF BETA ANTAGONISTS
159 20170233443 CYCLIC POLYPEPTIDES FOR THE TREATMENT OF HEART FAILURE
160 20170233433 COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS
161 20170233432 19-NOR NEUROACTIVE STEROIDS AND METHODS OF USE THEREOF
162 20170233413 SUBSTITUTED ANNULATED PYRIMIDINES AND USE THEREOF
163 20170233404 ISOERGOLINE COMPOUNDS AND USES THEREOF
164 20170233402 TETRAHYDROISOQUINOLINE DERIVATIVES
165 20170233390 Methyl- and Trifluoromethyl-Substituted Pyrrolopyridine Modulators of RORC2 and Methods of Use Thereof
166 20170233387 ISOERGOLINE COMPOUNDS AND USES THEREOF
167 20170233381 DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE
168 20170233378 1-OXO-1,2-DIHYDROISOQUINOLIN-7-YL-(5-SUBSTITUTED-THIOPHEN-2-YL)-SULFONAMID- E COMPOUNDS, FORMULATIONS CONTAINING THOSE COMPOUNDS, AND THEIR USE AS AICARFT INHIBITORS IN THE TREATMENT OF CANCERS
169 20170233371 RORC2 INHIBITORS AND METHODS OF USE THEREOF
170 20170233368 ARYL AND HETEROARYL FUSED LACTAMS
171 20170233327 A METHOD AND APPARATUS FOR PRODUCING BIOFUEL IN AN OSCILLATING FLOW PRODUCTION LINE UNDER SUPERCRITICAL FLUID CONDITIONS
172 20170233321 METHOD FOR PRODUCTION OF 3-HYDROXYPROPAN-1-ONE COMPOUND, METHOD FOR PRODUCTION OF 2-PROPEN-1-ONE COMPOUND AND METHOD FOR PRODUCTION OF ISOXAZOLINE COMPOUND
173 20170232361 VAPOR TRAP
174 20170232034 METHOD TO ALLEVIATE JOINT PAIN USING LOW MOLECULAR WEIGHT HYALURONIC ACID AND JOINT CARE COMPONENTS, INCLUDING TYPE II COLLAGEN
175 20170231999 IDO INHIBITORS
176 20170231992 COMPOUNDS FOR USE IN TREATING ACUTE CORONARY SYNDROME AND RELATED CONDITIONS
177 20170231981 COMPOSITIONS OF MULTIPLE ARIPIPRAZOLE PRODRUGS
178 20170231976 8'-HYDROXY-DIHYDROERGOTAMINE COMPOUNDS AND COMPOSITIONS
179 20170231973 QUINOLINE CONTAINING COMPOUNDS AND THEIR USE FOR TREATING ENDOPLASMIC RETICULUM STRESS-RELATED DISEASES
180 20170231914 A method and a device for producing nanoparticles
181 20170231894 NON-TACKY GEL-TYPE COSMETIC COMPOSITION WITH IMPROVED WEAR PROPERTY
182 20170231262 NUTRITIONAL COMPOSITIONS CONTAINING STRUCTURED FAT GLOBULES AND USES THEREOF
183 20170229297 Intelligent Dynamic Range Enhancement
184 20170227510 Analyte Detection Devices, Multiplex and Tabletop Devices for Detection of Analytes, and Uses Thereof
185 20170226901 Power Generation System And Method With Partially Recuperated Flow Path
186 20170226330 FLUID COMPOSITION COMPRISING LIGNIN
187 20170226307 MICROPOROUS POLYOLEFIN-BASED AEROGELS
188 20170226145 METHODS OF EXTRACTION AND PURIFICATION FROM STEVIA REBAUDIANA OF COMPOSITIONS WITH ENHANCED REBAUDIOSIDE-M CONTENT, USES OF SAID COMPOSITION AND NATURAL SWEETENER COMPOSITIONS WITH SAID COMPOSITION
189 20170226132 TRIAZOLOPYRIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
190 20170226103 DIFLUOROPYRROLIDINES AS OREXIN RECEPTOR MODULATORS
191 20170226102 INDOLES FOR USE IN INFLUENZA VIRUS INFECTION
192 20170226089 SUBSTITUTED 1,2,3-TRIAZOLES AS NR2B-SELECTIVE NMDA MODULATORS
193 20170226088 SYNTHESIS OF CHIRAL 2-(1H-INDAZOL-6-YL)-SPIRO[CYCLOPROPANE-1,3'-INDOLIN]-2'-ONES
194 20170226067 PIPERAZINE DERIVATIVES AS LIVER X RECEPTOR MODULATORS
195 20170226042 DEVICE METHOD OF MAKING ARTEPILLIN C IN PROPOLIS FOR ANTI-CANCER
196 20170226021 ENHANCED CARBONATION AND CARBON SEQUESTRATION IN CEMENTITIOUS BINDERS
197 20170225372 PROCESS AND DEVICE FOR PRODUCING FOAMED MOLDED OBJECT
198 20170224842 CONTROLLED-RELEASE AND STRATIFIED CYCLODEXTRIN INCLUSION COMPLEX VEHICLES
199 20170224841 CONTROLLED-RELEASE AND STRATIFIED CYCLODEXTRIN INCLUSION COMPLEX VEHICLES
200 20170224706 AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS AND USES THEREOF
201 20170224702 COMBINATION ALZHEIMER THERAPY USING ANTI-N3PGLU ABETA ANTIBODIES + A BACE INHIBITOR
202 20170224697 3-(1H-IMIDAZO[4,5-C]PYRIDIN-2-YL)-1H-PYRAZOLO[3,4-B]PYRIDINE AND THERAPEUTIC USES THEREOF
203 20170224658 Mono- or di-substituted indoles as dengue viral replication inhibitors
204 20170224650 Methods for Making Compound Particles
205 20170224597 SOAP BASED SUNSCREEN COMPOSITION
206 20170224401 CRYOCLAMP AND METHOD OF USE
207 20170223996 Antioxidant Producing Bacterium and Uses Thereof
208 20170222090 PROTECTIVE CAPPING LAYER FOR SPALLED GALLIUM NITRIDE
209 20170221690 Method of Introducing Ions into a Vacuum Region of a Mass Spectrometer
210 20170221643 Supercapacitor electrode having highly oriented and closely packed graphene sheets and production process
211 20170219600 METHODS FOR CHARACTERIZING COMPOSITIONS COMPRISING PEANUT ANTIGENS
212 20170218528 HOMOGENEOUSLY DISPERSED MULTIMETAL OXY-HYDROXIDE CATALYSTS
213 20170218346 Heme Protein Catalysts for Carbon-Silicon Bond Formation In Vitro and In Vivo
214 20170218257 FLUOROSURFACTANT EXTRACTION PROCESS FOR CARBONATE RESERVOIRS
215 20170218164 THERMOCHEMICAL PROCESS FOR RECOVERING FIBERGLASS REINFORCED PLASTICS WASTE MATTER
216 20170218160 METHOD FOR ONE-STEP SYNTHESIS, CROSS-LINKING AND DRYING OF AEROGELS
217 20170218132 METHOD OF MAKING PLASTIC ARTICLE
218 20170218025 BOUVARDIN DERIVATIVES AND THERAPEUTIC USES THEREOF
219 20170217991 NOVEL 3-AMINO-PYRROLO[3,4-C]PYRAZOLE-5(1H, 4H,6H) CARBALDEHYDE DERIVATIVES
220 20170217990 NOVEL COMPOUNDS FOR THE TREATMENT OF INFECTIOUS DISEASES
221 20170217981 INHIBITORS OF IRAK4 ACTIVITY
222 20170217973 NOVEL COMPOUNDS FOR USE IN COGNITION IMPROVEMENT
223 20170217972 6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
224 20170217971 6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
225 20170217950 Bicyclo[3.2.1]Octyl Amide Derivatives and Uses of Same
226 20170217942 [7,6]-FUSED BICYCLIC ANTIDIABETIC COMPOUNDS
227 20170217940 FUSED TETRACYCLIC HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES
228 20170217936 PYRROLIDINYL UREA, PYRROLIDINYL THIOUREA AND PYRROLIDINYL GUANIDINE COMPOUNDS AS TRKA KINASE INHIBITORS
229 20170217930 PYRROLIDINE GPR40 MODULATORS FOR THE TREATMENT OF DISEASES SUCH AS DIABETES
230 20170217920 ANTIDIABETIC BICYCLIC COMPOUNDS
231 20170217918 ANTIDIABETIC BICYCLIC COMPOUNDS
232 20170217904 SALTS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR
233 20170217058 POLYMERIC MATERIAL FOR CONTAINER
234 20170216775 UPGRADING PROCESS STREAMS
235 20170216439 OTIC FORMULATIONS FOR THE TREATMENT OF CERUMINOSIS
236 20170216325 (R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-METHYLBENZ- YL)PYRROLIDIN-2-ONE AND ITS PRODRUGS FOR THE TREATMENT OF PSYCHIATRIC DISORDERS
237 20170216299 3-(3H-IMIDAZO[4,5-C]PYRIDIN-2-YL)-1H-PYRAZOLO[3,4-C]PYRIDINE AND THERAPEUTIC USES THEREOF
238 20170216290 HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME
239 20170216283 COMPOUNDS AND USES
240 20170216263 ARYL DIHYDROPYRIDINONES AND PIPERIDINONE MGAT2 INHIBITORS
241 20170216262 AMIDO SPIROCYCLIC AMIDE AND SULFONAMIDE DERIVATIVES
242 20170216229 GLUCAGON ANTAGONISTS
243 20170216153 AEROGELS, CALCINED AND CRYSTALLINE ARTICLES AND METHODS OF MAKING THE SAME
244 20170215464 NUTRITIONAL COMPOSITIONS CONTAINING DIETARY BUTYRATE AND USES THEREOF
245 20170213716 Method for Separating Ions According to a Physicochemical Property
246 20170213713 Multipath Duty Cycle Enhancement
247 20170213700 Plasma Treatment Method to Meet Line Edge Roughness and Other Integration Objectives
248 20170212081 Mobility Selective Attenuation
249 20170211881 METHOD AND SYSTEM FOR PROVIDING AUXILIARY REFRIGERATION TO AN AIR SEPARATION PLANT
250 20170211849 PROCESS AND METHOD OF PRODUCING GEOTHERMAL POWER
251 20170211550 COMBINED POWER GENERATION SYSTEM BASED ON GEOTHERMAL ENERGY AND SOLAR ENERGY AND POWER GENERATION METHOD THEREOF
252 20170211013 LIPID COMPRISING LONG CHAIN POLYUNSATURATED FATTY ACIDS
253 20170211000 PROCESS FOR PRODUCING DIESEL WITH LOW LEVELS OF SULFUR
254 20170210760 CRYSTALLINE FREE BASES OF C-MET INHIBITOR OR CRYSTALLINE ACID SALTS THEREOF, AND PREPARATION METHODS AND USES THEREOF
255 20170210733 BENZOXAZEPIN OXAZOLIDINONE COMPOUNDS AND METHODS OF USE
256 20170210732 Factor XIa Inhibitors
257 20170210727 [5,6]-FUSED BICYCLIC ANTIDIABETIC COMPOUNDS
258 20170210725 6-MEMBERED AZA-HETEROCYCLIC CONTAINING DELTA-OPIOID RECEPTOR MODULATING COMPOUNDS, METHODS OF USING AND MAKING THE SAME
259 20170210724 ALKYNYL ALCOHOLS AND METHODS OF USE
260 20170210715 MONOCYCLIC ISOXAZOLINES AS INHIBITORS OF CHOLESTEROL ESTER TRANSFER PROTEIN
261 20170210704 DEUTERO-PHENFORMIN DERIVATIVES
262 20170210108 LAMINATES COMPRISING REINFORCED AEROGEL COMPOSITES
263 20170210093 LAMINATES COMPRISING REINFORCED AEROGEL COMPOSITES
264 20170210092 INSULATING STRUCTURES
265 20170209603 COMPOSITIONS TARGETING RADIATION-INDUCED MOLECULES AND METHODS OF USE THEREOF
266 20170209592 Delivery Agents Targeted to Degraded Elastic Fibers
267 20170209567 METHODS FOR EFFECTIVELY AND RAPIDLY DESENSITIZING ALLERGIC PATIENTS
268 20170209514 Method For Promoting Bone Length Growth
269 20170209461 Treatment Of Conditions Associated With Hyperinsulinaemia
270 20170209411 Use of butylidenephthalide (Bdph), method of using the same, and method for preparing pharmaceutical composition containing the same
271 20170209408 HSP90 INHIBITORS FOR THE TREATMENT OF OBESITY AND METHODS OF USE THEREOF
272 20170209372 A Method of Preparing Amorphous Solid Dispersion in Submicron Range by Co-Precipitation
273 20170208827 ENCAPSULATED AMORPHOUS CALCIUM CARBONATE COMPOSITIONS
274 20170208806 MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO
275 20170207489 Method of producing alkali metal or alkali-ion batteries having high volumetric and gravimetric energy densities
276 20170207488 Production process for alkali metal-sulfur batteries having high volumetric and gravimetric energy densities
277 20170207484 Alkali Metal-Sulfur Batteries Having High Volumetric and Gravimetric Energy Densities
278 20170207073 Histogramming Different Ion Areas on Peak Detecting Analogue to Digital Convertors
279 20170205639 EYEWEAR WITH CHROMA ENHANCEMENT
280 20170204262 FLOWABILITY IMPROVER FOR POLYCARBONATE AND POLYARYLATE, POLYCARBONATE RESIN COMPOSITION, POLYARYLATE RESIN COMPOSITION, AND MOLDED ARTICLE THEREOF
281 20170204207 Separation Vessels For Use In Polymerization Processes and Methods For Cleaning Same
282 20170204133 BETULINIC ACID DERIVATIVES WITH HIV MATURATION INHIBITORY ACTIVITY
283 20170204110 COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS
284 20170204106 SELECTIVE DUAL INHIBITORS OF PI3 DELTA AND GAMMA PROTEIN KINASES
285 20170204100 Chemical Compounds
286 20170204098 NOVEL COMPOUNDS USEFUL AS S100-INHIBITORS
287 20170204096 Substituted 2-Azabicycles And Their Use As Orexin Receptor Modulators
288 20170203552 Thermally Insulative Expanded Polytetrafluoroethylene Articles
289 20170203384 METHODS AND SYSTEMS FOR RECYCLING CARBON FIBER
290 20170202860 Compositions of Vitamin D and Methods for Their Use and Manufacture
291 20170202855 SOLID GANAXOLONE COMPOSITIONS AND METHODS FOR THE MAKING AND USE THEREOF
292 20170200938 GRAPHENE-ENHANCED ANODE PARTICULATES FOR LITHIUM ION BATTERIES
293 20170200597 Ion Guide
294 20170200594 Hybrid Mass Spectrometer
295 20170200565 Supercapacitor having highly conductive graphene foam electrode
296 20170199461 PATTERN FORMING METHOD, RESIST PATTERN, AND PROCESS FOR PRODUCING ELECTRONIC DEVICE
297 20170199460 PATTERN FORMING METHOD, RESIST PATTERN, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE
298 20170199153 Segmented Linear Ion Mobility Spectrometer Driver
299 20170198416 METHODS AND SYSTEMS FOR RECOVERING CARBON FIBERS FROM OBJECTS
300 20170198064 METHOD FOR PRODUCING CLEAN THERMOPLASTIC PARTICLES
301 20170197989 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL
302 20170197965 Imidazopyridazine Derivatives As Modulators of the GABAA Receptor Activity
303 20170197964 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL
304 20170197959 Pyridopyrimidinedione derivatives
305 20170197953 FACTOR XIa INHIBITORS
306 20170197950 THIOPHEN-2-YL-PYRIDIN-2-YL-1H-PYRAZOLE-4-CARBOXYLIC ACID DERIVATIVES AND THE USE THEREOF AS SOLUBLE GUANYLATE CYCLASE ACTIVATORS
307 20170197941 CYCLOHEXEN-1-YL-PYRIDIN-2-YL-1H-PYRAZOLE-4-CARBOXYLIC ACID DERIVATIVES AND THE USE THEREOF AS SOLUBLE GUANYLATE CYCLASE ACTIVATORS
308 20170197940 INDANE AND INDOLINE DERIVATIVES AND THE USE THEREOF AS SOLUBLE GUANYLATE CYCLASE ACTIVATORS
309 20170197939 Tropomyosin-Related Kinase Inhibitors Containing Both A 1H-Pyrazole And A Pyrimidine Moiety
310 20170197934 SOLID FORMS OF 2-(4-CHLOROPHENYL)-N-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-5-YL)M- ETHYL)-2,2-DIFLUOROACETAMIDE, AND THEIR PHARMACEUTICAL COMPOSITIONS AND USES
311 20170197931 APPARATUS AND METHOD FOR PRODUCING CYCLIC CARBONATE
312 20170197918 Allosteric Modulators of CB1 Cannabinoid Receptors
313 20170197916 FUNCTIONALIZED PEGYLATED CYANINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF
314 20170197194 PROCESSING MATERIALS
315 20170197156 NEW ULTRAHIGH EFFICIENCY, SUPERFICIALLY POROUS PARTICLE (SPP) CHIRAL PHASES FOR LIQUID CHROMATOGRAPHY
316 20170196989 RADIATION-STERILIZED BIODEGRADABLE DRUG DELIVERY COMPOSITIONS
317 20170196982 MACROLIDE DOSAGE FORMS
318 20170196979 LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS
319 20170196929 PHYTO-ACTIVE BASED ANTI-CANCER FORMULATION
320 20170196865 TREATMENT OF AUTOIMMUNE DISEASE
321 20170196862 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
322 20170196861 METHOD OF THERAPEUTIC ADMINISTRATION OF DHE TO ENABLE RAPID RELIEF OF MIGRAINE WHILE MINIMIZING SIDE EFFECT PROFILE
323 20170194801 ELECTRICITY STORAGE DEVICE USING HIGH-PRESSURE GAS MEDIUM AND METHOD THEREOF
324 20170194449 METHOD OF MAKING A GALLIUM NITRIDE DEVICE
325 20170191379 Systems and Methods for Controlling Backpressure in a Heat Engine System Having Hydrostaic Bearings
326 20170191010 Bactericidal, Fungicidal and Anti-Allergenic Zanthoxylum Schinifolium Skin Care Soap and Method of Preparation
327 20170190953 SURFACTANT FORMULATIONS FOR FOAM FLOODING
328 20170190850 Methods, processes, and apparatuses for producing welded substrates
329 20170190757 Novel Glucagon Analogues
330 20170190728 HIGH-PURITY STEVIOL GLYCOSIDES
331 20170190701 FUSED TRICYCLIC HETEROCYCLIC COMPOUNDS AS HIV INTEGRASE INHIBITORS
332 20170190693 SUBSTITUTED CHROMANES AND METHOD OF USE
333 20170190683 HIGHLY PURIFID PHARMACEUTICAL GRADE TASIMELTEON
334 20170190681 1-(CYCLOPENT-2-EN-1-YL)-3-(2-HYDROXY-3-(ARYLSULFONYL)PHENYL)UREA DERIVATIVES AS CXCR2 INHIBITORS
335 20170190633 METHOD FOR THE BIOACTIVATION OF BIOCHAR FOR USE AS A SOIL AMENDMENT
336 20170189831 SYSTEMS AND METHODS FOR SUPERCRITICAL FLUID CHROMATOGRAPHY
337 20170189569 BIODEGRADABLE MICROSPHERES INCORPORATING RADIONUCLIDES TECHNICAL FIELD
338 20170189529 ANTIBODIES USEFUL IN PASSIVE INFLUENZA IMMUNIZATION, AND COMPOSITIONS, COMBINATIONS AND METHODS FOR USE THEREOF
339 20170189503 PCSK9 VACCINE AND METHODS OF USING THE SAME
340 20170189419 PHARMACEUTICAL COMPOSITION FOR TREATING PROSTATE CANCER
341 20170189418 PHARMACEUTICAL COMPOSITION FOR TREATING LUNG CANCER
342 20170189417 PHARMACEUTICAL COMPOSITION FOR TREATING COLORECTAL CANCER
343 20170189416 PHARMACEUTICAL COMPOSITION FOR TREATING BREAST CANCER
344 20170189397 HEADACHE PRE-EMPTION BY DIHYDROERGOTAMINE TREATMENT DURING HEADACHE PRECURSOR EVENTS
345 20170189383 PPAR COMPOUNDS FOR USE IN THE TREATMENT OF FIBROTIC DISEASES
346 20170189329 METHOD OF PREPARING A PHARMACEUTICAL COMPOSITION
347 20170189282 ANHYDROUS SOFT SOLID COMPOSITION BASED ON PARTICLES ENCAPSULATING A BENEFICIAL AGENT
348 20170189278 GEL-TYPE COSMETIC COMPOSITION
349 20170187028 METHOD FOR MANUFACTURING ENERGY-STORAGE COMPOSITE MATERIAL
350 20170186594 Monitoring Liquid Chromatography Elution to Determine When to Perform a Lockmass Calibration
351 20170184974 PATTERN FORMING METHOD, RESIST PATTERN, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE
352 20170184973 ORGANIC TREATMENT LIQUID FOR PATTERNING RESIST FILM, METHOD OF PRODUCING ORGANIC TREATMENT LIQUID FOR PATTERNING RESIST FILM, STORAGE CONTAINER OF ORGANIC TREATMENT LIQUID FOR PATTERNING RESIST FILM, PATTERN FORMING METHOD USING THE SAME, AND METHOD OF PRODUCING ELECTRONIC DEVICE
353 20170184970 PATTERN FORMING METHOD, COMPOSITION FOR FORMING UPPER LAYER FILM, RESIST PATTERN, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE
354 20170184553 Volumetric Flow Regulation in Multi-Dimensional Liquid Analysis Systems
355 20170184344 SELF-COOLING BEVERAGE CONTAINER HAVING A HEAT EXCHANGE UNIT USING LIQUID CARBON DIOXIDE
356 20170183996 Gas Separation Process Using Membranes with Permeate Sweep to Remove CO2 from Combustion Exhaust
357 20170183470 AMINO-CONTAINING SILICA PARTICLE, COMPOSITION FOR FORMING POLYIMIDE AEROGEL, POLYIMIDE AEROGEL AND METHOD OF FABRICATING THE SAME, POLYIMIDE AEROGEL-CONTAINING COMPOSITE MATERIAL
358 20170183354 SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
359 20170183342 6,7-DIHYDRO-5H-PYRROLO[3,4-B]PYRIDIN-5-ONE ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR
360 20170183330 BENZIMIDAZOLE DERIVATIVES AS ERBB TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCER
361 20170183326 COCRYSTAL, PRODUCTION METHOD THEREOF, AND MEDICAMENT CONTAINING COCRYSTAL
362 20170182558 USE OF REACTIVE FLUIDS IN ADDITIVE MANUFACTURING AND THE PRODUCTS MADE THEREFROM
363 20170182523 TREATMENT METHOD AND DEVICE USING A SUPERCRITICAL FLUID AND INJECTION OF ADDITIVE
364 20170182522 TREATMENT METHOD AND DEVICE USING A SUPERCRITICAL FLUID AND A DISCHARGE STORAGE VOLUME
365 20170182486 METAL-ORGANIC FRAMEWORKS CONTAINING NITROGEN-DONOR LIGANDS FOR EFFICIENT CATALYTIC ORGANIC TRANSFORMATIONS
366 20170182459 SYSTEM AND METHOD FOR REDUCING LIQUID DISCHARGE FROM ONE OR MORE DEVICES
367 20170182106 COMPOSITION INCLUDING KIRENOL OR SIEGESBECKIA HERBA EXTRACT FOR MUSCLE FUNCTION IMPROVEMENT OR EXERCISE ABILITY ENHANCEMENT
368 20170182068 CORTICOSTEROIDS FOR THE TREATMENT OF JOINT PAIN
369 20170182061 NEW USES OF GANAXOLONE
370 20170182056 QUINOLINYL MODULATORS OF RORyt
371 20170181978 POLYMER PROTEIN MICROPARTICLES
372 20170181940 APPARATUS AND METHOD FOR PREPARING COSMECEUTICAL INGREDIENTS CONTAINING EPI-DERMAL DELIVERY MECHANISMS
373 20170181937 APPARATUS AND METHOD FOR PREPARING COSMECEUTICAL INGREDIENTS CONTAINING EPI-DERMAL DELIVERY MECHANISMS
374 20170181936 APPARATUS AND METHOD FOR PREPARING COSMECEUTICAL INGREDIENTS CONTAINING EPI-DERMAL DELIVERY MECHANISMS
375 20170181498 Footwear Compositions Comprising Propylene-Based Elastomers
376 20170178883 Method to Remove Ion Interferences
377 20170178880 Two Dimensional MS/MS Acquisition Modes
378 20170176874 EXPOSURE APPARATUS, EXPOSURE METHOD, AND DEVICE PRODUCING METHOD
379 20170176862 PATTERN FORMING METHOD, COMPOSITION FOR FORMING PROTECTIVE FILM, METHOD FOR MANUFACTURING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE
380 20170176855 RESIST COMPOSITION, METHOD FOR FORMING RESIST PATTERN, ACID GENERATOR AND COMPOUND
381 20170176401 Secondary Ultrasonic Nebulisation
382 20170175624 GAS TURBINE FACILITY
383 20170174979 SUSPENSIONS FOR ENHANCED OIL RECOVERY
384 20170174891 NATURAL CRYSTALLINE COLORANT AND PROCESS FOR PRODUCTION
385 20170174890 NATURAL CRYSTALLINE COLORANT AND PROCESS FOR PRODUCTION
386 20170174856 THERMOPLASTIC POLYMER FOAMING SOLE AND METHOD FOR MANUFACTURING THERMOPLASTIC POLYMER FOAMING SOLE
387 20170174801 NON-CHEMICAL AMPLIFICATION TYPE RESIST COMPOSITION, NON-CHEMICAL AMPLIFICATION TYPE RESIST FILM, PATTERN FORMING METHOD, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE
388 20170174717 METHOD OF SEPARATING BETANIN FROM RED QUINOA BY SUPERCRITICAL FLUID FRACTIONATION
389 20170174697 BENZIMIDAZOLE DERIVATIVES AS ERBB TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCER
390 20170174695 NEW SPIRO[3H-INDOLE-3,2'-PYRROLIDIN]-2(1H)-ONE COMPOUNDS AND DERIVATIVES AS MDM2-P53 INHIBITORS
391 20170174693 SOLUBLE GUANYLATE CYCLASE STIMULATORS
392 20170174690 SUBSTITUTED 4,5,6,7-TETRAHYDRO-PYRAZOLO[1,5-a]PYRAZINE DERIVATIVES AND 5,6,7,8-TETRAHYDRO-4H-PYRAZOLO[1,5-a][1,4]DIAZEPINE DERIVATIVES AS ROS1 INHIBITORS
393 20170174688 Substituted Indoles
394 20170174685 ERGOLINE COMPOUNDS AND USES THEREOF
395 20170174684 ERGOLINE COMPOUNDS AND USES THEREOF
396 20170174680 P2X7 MODULATORS
397 20170174674 HYDROXYALKYLAMINE- and HYDROXYCYCLOALKYLAMINE-SUBSTITUTED DIAMINE-ARYLSULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS
398 20170174672 FUSED (HETERO)CYCLIC COMPOUNDS AS S1P MODULATORS
399 20170174633 PYRAZOLE COMPOUNDS SELECTIVE FOR NEUROTENSIN 2 RECEPTOR
400 20170174628 PYRIDINE DERIVATIVES AND ANTI-MYCOBACTERIAL USE THEREOF
401 20170174624 PRIMARY CARBOXAMIDES AS BTK INHIBITORS
402 20170174608 Synthetic Method
403 20170174576 FLEXIBLE COMPOSITE AEROGEL AND PROCESS FOR PRODUCING SAME
404 20170173572 CHIRAL LIGAND-BASED METAL-ORGANIC FRAMEWORKS FOR BROAD-SCOPE ASYMMETRIC CATALYSIS
405 20170173560 POROUS CYCLODEXTRIN POLYMERIC MATERIALS AND METHODS OF MAKING AND USING SAME
406 20170173559 A POROUS METAL-ORGANIC FRAMEWORK WITH PYRIMIDINE GROUPS FOR METHANE STORAGE EXHIBITING HIGH WORKING CAPACITY
407 20170173513 RETICULATED ANNULAR CAPILLARY GAS CHROMATOGRAPHY COLUMN AND METHOD FOR FORMING RETICULATED ANNULAR CAPILLARY GAS CHROMATOGRAPHY COLUMN
408 20170173497 DEVICE, APPARATUS AND METHOD FOR PERFORMING SEPARATIONS
409 20170173496 LOW-RETENTION PRE-COLUMNS: A STRAIGHTFORWARD APPROACH TO ENABLE LARGER INJECTION VOLUMES AND REDUCE EXTRA-COLUMN EFFECTS IN HPLC
410 20170173495 FLUID DISTRIBUTION UNIT FOR A CHROMATOGRAPHY COLUMN
411 20170173222 METHOD OF FABRICATING AN IMPLANTABLE MEDICAL DEVICE COMPRISING A RAPAMYCIN DERIVATIVE
412 20170173178 FORMULATIONS CONTAINING CLOPIDOGREL AND SULFOALKYL ETHER CYCLODEXTRIN AND METHODS OF USE
413 20170173162 Natural Preservatives and Antimicrobial Agents, Including Compositions Thereof
414 20170173142 COMPOSITIONS OF MULTIMERIC-MULTIEPITOPE INFLUENZA POLYPEPTIDES AND THEIR PRODUCTION
415 20170173059 Novel Combination of Naturally Occurring Compounds to Assist With Suspected Mycobacterial Infections Related to Autoimmune Conditions
416 20170173035 BETA-TETRAZOLYL-PROPIONIC ACIDS AS METALLO-BETA-LACTAMASE INHIBITORS
417 20170173017 FUSED BICYCLIC 2,4-DIAMINOPYRIMIDINE DERIVATIVE AS A DUAL ALK AND FAK INHIBITOR
418 20170173014 SUBSTITUTED 4,5,6,7-TETRAHYDRO-PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AND 2,3-DIHYDRO-1H-IMIDAZO[1,2-b]PYRAZOLE DERIVATIVES AS ROS1 INHIBITORS
419 20170173010 IMMEDIATE RELEASE PHARMACEUTICAL FORMULATION OF 4-[3-(4-CYCLOPROPANECARBONYL-PIPERAZINE-1-CARBONYL)-4-FLUORO-BENZYL]-2H-P- HTHALAZIN-1-ONE
420 20170173006 PARTICULATE MATERIALS
421 20170172977 Microencapsulated Cannabinoid Compositions
422 20170172961 PHARMACEUTICAL SUSPENSIONS CONTAINING DRUG PARTICLES, DEVICES FOR THEIR ADMINISTRATION, AND METHODS OF THEIR USE
423 20170172863 Apparatus and Method for Preparing Cosmeceutical Ingredients Containing Epi-Dermal Delivery Mechanisms
424 20170169999 Compact Mass Spectrometer
425 20170168394 ACTIVE-LIGHT-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, PATTERN FORMING METHOD, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE
426 20170168029 LC-MS CONFIGURATION FOR PURIFICATION AND DETECTION OF ANALYTES HAVING A BROAD RANGE OF HYDROPHOBICITES
427 20170167476 PUMPING SYSTEM FOR CHROMATOGRAPHY APPLICATIONS
428 20170167442 DEVICE, SYSTEM, AND METHOD FOR PRESSURIZING AND SUPPLYING FLUID
429 20170166837 METHOD FOR PRODUCING VITAMIN E-ENRICHED, ESPECIALLY TOCOTRIENOL-ENRICHED, COMPOSITIONS FROM NATURAL OILS
430 20170166616 CHIMERIC INHIBITOR MOLECULES OF COMPLEMENT ACTIVATION
431 20170166578 ANTIDIABETIC SUBSTITUTED HETEROARYL COMPOUNDS
432 20170166574 NOVEL COMPOUNDS
433 20170166566 SUBSTITUTED PYRIDO[1,2-a]PYRAZINES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
434 20170166553 Piperidine Derivatives for Use in the Treatment or Prevention of Psychiatric and Neurological Conditions
435 20170166527 Novel Compounds
436 20170165946 VACUUM INSULATION PANEL COMPRISING AN ORGANIC AEROGEL
437 20170165876 METHOD AND APPARATUS FOR RECOVERING FIBER ASSEMBLY FROM THERMOSETTING RESIN COMPOSITE MATERIALS AND RECOVERED FIBER ASSEMBLY THEREBY
438 20170165628 CONTROLLING PROCESS GASES
439 20170165591 CHROMATOGRAPHY FILTER
440 20170165270 Heteroaromatic Compounds and their Use as Dopamine D1 Ligands
441 20170165243 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HYPER-PROLIFERATIVE DISORDERS
442 20170165234 GPR142 Agonist Compounds
443 20170165230 USE OF GSK-3 INHIBITORS OR ACTIVATORS WHICH MODULATE PD-1 OR T-BET EXPRESSION TO MODULATE T CELL IMMUNITY
444 20170165193 TOPICAL SKIN CARE FORMULATIONS COMPRISING PLANT EXTRACTS
445 20170162374 Improved Quadrupole Robustness
446 20170160136 PROCESS AND SYSTEM FOR SAMPLE ANALYSIS
447 20170159978 SYSTEMS AND METHODS FOR MULTI-STAGE REFRIGERATION
448 20170159403 Sealing Devices, Wellbore Tubulars Including The Sealing Devices, And Hydrocarbon Wells Including The Wellbore Tubulars
449 20170159077 PROCESSING BIOMASS
450 20170158784 Polymerization Product Pressures in Olefin Polymerization
451 20170158781 ALKYLATED CYCLODEXTRIN COMPOSITIONS AND PROCESSES FOR PREPARING AND USING THE SAME
452 20170158711 NOVEL INDUSTRIAL CRYSTALLIZATION METHOD OF CEFUROXIME SODIUM AND PREPARATION THEREOF
453 20170158703 METHOD FOR PRODUCING SPIROOXINDOLE DERIVATIVE
454 20170158698 TrKA Kinase Inhibitors, Compositions and Methods Thereof
455 20170158693 HEXAHYDRODIAZEPINOQUINOLINES CARRYING A CYCLIC RADICAL
456 20170158683 COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY
457 20170158678 SUBSTITUTED PYRIDINE DERIVATIVES USEFUL AS C-FMS KINASE INHIBITORS
458 20170158652 PROCESS FOR PREPARING SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES
459 20170158627 SUBSTITUTED BIARYL SULFONAMIDES AND THE USE THEREOF
460 20170158579 3-(5-SUBSTITUTED-4-OXOQUINAZOLIN-3(4H)-YL)-3-DEUTERO-PIPERIDINE-2,6-DIONE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME
461 20170157654 METHOD AND SYSTEM FOR THE IN-SITU DECONTAMINATION OF CONTAMINATED SOILS
462 20170157529 OIL SEPARATION SYSTEM
463 20170157528 METHOD FOR PRODUCING COCRYSTALS BY MEANS OF FLASH EVAPORATION
464 20170157242 SYNERGISTIC NUTRITIONAL COMPOSITIONS AND USES THEREOF
465 20170157141 METHOD OF TREATING LEUKEMIA USING PHARMACEUTICAL FORMULATION CONTAINING THIENOTRIAZOLODIAZEPINE COMPOUNDS
466 20170157133 NOVEL PYRIDAZONES AND TRIAZINONES FOR TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION
467 20170157028 TOPICAL SKIN CARE FORMULATIONS COMPRISING PLANT EXTRACTS
468 20170156455 BRACELET OR STRAP
469 20170152627 METHOD FOR MARKING A TEXTILE THREAD WITH A FLUORESCENT ELEMENT, TEXTILE THREAD PRODUCED BY THE MARKING METHOD, AND USE OF SAID TEXTILE THREAD FOR WEAVING AN ITEM OF CLOTHING
470 20170152451 UPGRADING OF HYDROCARBON MATERIAL
471 20170152440 ENHANCING BIOCHAR PERFORMANCE USING PYROLYSIS ACID STREAM
472 20170152329 MITIGATION OF WAX LEVELS IN THE HIGH PRESSURE LOW DENSITY POLYETHYLENE PROCESS
473 20170152328 UNIFIED COOLING FOR MULTIPLE POLYOLEFIN POLYMERIZATION REACTORS
474 20170152327 UNIFIED COOLING FOR MULTIPLE POLYOLEFIN POLYMERIZATION REACTORS
475 20170152277 METHODS OF FORMING THIN FILM AND FABRICATING INTEGRATED CIRCUIT DEVICE USING NIOBIUM COMPOUND
476 20170152269 FUSED BICYCLIC COMPOUNDS AND THEIR USE AS CDK INHIBITORS
477 20170152256 3,5-DICHLORO,4-(3,4-(CYCLO-)ALKOXYPHENYL)--2-CARBONYLOXY)ETHYL)PYRIDINE DERIVATIVES AS PDE-4 INHIBITORS
478 20170152239 BENZAMIDE AND HETEROBENZAMIDE COMPOUNDS
479 20170152194 METHOD FOR ENHANCING SOIL GROWTH USING BIO-CHAR
480 20170151747 RESIN SANDWICH PANEL, AND METHOD FOR MANUFACTURING RESIN SANDWICH PANEL
481 20170151549 ALKYLAMINE FUNCTIONALIZED METAL-ORGANIC FRAMEWORKS FOR COMPOSITE GAS SEPARATIONS
482 20170151339 TARGETED CONJUGATES AND PARTICLES AND FORMULATIONS THEREOF
483 20170151321 CHIMERIC PESTIVIRUSES
484 20170151297 METHOD FOR IMPROVING MITOCHONDRIA AND METHOD FOR PROMOTING CELL DIVISION OF STEM CELL
485 20170151269 GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF
486 20170151268 GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF
487 20170151266 METHODS AND COMPOSITIONS FOR ENHANCED DRUG DELIVERY TO THE EYE AND EXTENDED DELIVERY FORMULATIONS
488 20170151255 METHOD OF TREATING NON-SMALL CELL LUNG CANCER AND/OR SMALL CELL LUNG CANCER USING THIENOTRIAZOLODIAZEPINE COMPOUNDS
489 20170151225 QUINOLINE DERIVATIVES AND THEIR USE FOR TREATING ENDOPLASMIC RETICULUM STRESS-RELATED DISEASES AND DISORDERS
490 20170151173 COMPOSITIONS AND METHODS FOR OTOLOGIC PROPHYLAXIS AND TREATMENT
491 20170150724 BISMUTH-THIOLS AS ANTISEPTICS FOR AGRICULTURAL, INDUSTRIAL AND OTHER USES
492 20170149054 PROCESS FOR SILICON NANOWIRE-GRAPHENE HYBRID MAT
493 20170148635 METHOD FOR IMPROVING QUALITY OF SPALLED MATERIAL LAYERS
494 20170148624 SUPERCRITICAL CARBON DIOXIDE PROCESS FOR LOW-K THIN FILMS
495 20170148573 Method of producing supercapacitor electrodes and cells having high active mass loading
496 20170146908 PATTERN FORMING METHOD AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE USING SAME
497 20170146496 CATALYTIC REACTOR COUPLED WITH FLAME IONIZATION DETECTOR FOR LIQUID CHROMATOGRAPHY
498 20170145445 Process and Systems for the Fermentative Production of Alcohols
499 20170145034 ALKYNYL ALCOHOLS AND METHODS OF USE
500 20170145029 CYCLIC THIENOURACIL-CARBOXAMIDES AND USE THEREOF
[PREV_LIST] [NEXT_LIST]  

กก